Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-077073
Filing Date
2025-05-23
Accepted
2025-05-23 17:04:25
Documents
1
Period of Report
2025-05-22

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3749
  Complete submission text file 0000950170-25-077073.txt   5154
Mailing Address 1800 EL CAMINO REAL, SUITE D MENLO PARK CA 94027
Business Address 1800 EL CAMINO REAL, SUITE D MENLO PARK CA 94027 (650) 331-9090
AN2 Therapeutics, Inc. (Issuer) CIK: 0001880438 (see all company filings)

EIN.: 820606654 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 3835 CLEGHORN AVENUE, SUITE 300 NASHVILLE TN 37215
Business Address
Readnour Robin Shane (Reporting) CIK: 0001914883 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41331 | Film No.: 25983283